original ) (raw )The Role of Soluble LAG3 and Soluble Immune Checkpoints Profile in Advanced Head and Neck Cancer: A Pilot Study
Silvia Mezi
Journal of Personalized Medicine
View PDFchevron_right
Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma
Sacha Rothschild
Oncotarget, 2017
View PDFchevron_right
Oropharyngeal Squamous Cell Carcinoma Treatment in the Era of Immune Checkpoint Inhibitors
Tina Dalianis
Viruses
View PDFchevron_right
Cancer immunogenomic approach to neoantigen discovery in a checkpoint blockade responsive murine model of oral cavity squamous cell carcinoma
Dariusz Przybylski
Oncotarget, 2017
View PDFchevron_right
Immunosuppressive Microenvironment in Head and Neck Cancer
Merrill Biel
Contemporary Issues in Head and Neck Cancer Management, 2015
View PDFchevron_right
The dynamic role of immune checkpoint molecules in diagnosis, prognosis, and treatment of head and neck cancers
AFSHEEN RAZA
The dynamic role of immune checkpoint molecules in diagnosis, prognosis, and treatment of head and neck cancers, 2024
View PDFchevron_right
Expression of PD-L1 on Immune Cells Shows Better Prognosis in Laryngeal, Oropharygeal, and Hypopharyngeal Cancer
Zoltán Fent
Applied Immunohistochemistry & Molecular Morphology, 2018
View PDFchevron_right
Immune Checkpoint Inhibitors in Oral Cavity Squamous Cell Carcinoma and Oral Potentially Malignant Disorders: A Systematic Review
Omar Kujan
Cancers
View PDFchevron_right
Immune Checkpoints Pathways in Head and Neck Squamous Cell Carcinoma
Pedro Merlo
Cancers, 2021
View PDFchevron_right
The Immune Contexture and Cancer Therapy Aspects of the TIM-3 Checkpoint Pathway
Yunxuan Xie
E3S Web of Conferences, 2021
View PDFchevron_right
T-Cell Infiltration and Immune Checkpoint Expression Increase in Oral Cavity Premalignant and Malignant Disorders
Subin Surendran
Biomedicines
View PDFchevron_right
Recognizing and reversing the immunosuppressive tumor microenvironment of head and neck cancer
Charles Tong
Immunologic Research, 2012
View PDFchevron_right
PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients
Tudor Mocan
Scientific reports, 2016
View PDFchevron_right
Prognostic impact of immune microenvironment in laryngeal and pharyngeal squamous cell carcinoma: Immune cell subtypes, immuno-suppressive pathways and clinicopathologic characteristics
Marios Froudarakis
Oncotarget, 2016
View PDFchevron_right
Checkpoint Inhibitors in Cancer Therapy: Clinical Benefits for Head and Neck Cancers
Richard Bauer
Cancers
View PDFchevron_right
Evaluation of PD-L1 expression and Associated Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma
Margaritis Avgeris
Clinical cancer research : an official journal of the American Association for Cancer Research, 2015
View PDFchevron_right
Therapeutic Approaches With Immune Checkpoint Inhibitors in Head and Neck Cancers and the Role of PD-L1 as a Biomarker
Lamiae AMAADOUR
Cancer Control, 2021
View PDFchevron_right
Immune checkpoints in the tumor microenvironment
Neda Khosravi
Seminars in Cancer Biology, 2019
View PDFchevron_right
LAG3: The Biological Processes That Motivate Targeting This Immune Checkpoint Molecule in Human Cancer
Karen Willard-Gallo
Cancers
View PDFchevron_right
Immunohistochemical and Image Analysis-based Study Demonstrate that Several Immune Checkpoints are Co-expressed in Non-Small Cell Lung Carcinoma Tumors
Pamela Villalobos
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2018
View PDFchevron_right
Immunosuppressive microenvironment in oral cancer: implications for cancer immunotherapy
Anand Vaibhaw
2021
View PDFchevron_right
Characterization of the T-Cell Receptor Repertoire and Immune Microenvironment in Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck
Aiman Fatima
Clinical cancer research : an official journal of the American Association for Cancer Research, 2017
View PDFchevron_right
Tbet-positive regulatory T cells accumulate in oropharyngeal cancers with ongoing tumor-specific type 1 T cell responses
Marij Welters
Journal for ImmunoTherapy of Cancer
View PDFchevron_right
cancers Targeted Therapies and Immune-Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma: Where Do We Stand Today and Where to Go
michele pirrelli
View PDFchevron_right
Immune checkpoint expression on peripheral cytotoxic lymphocytes in cervical cancer patients: moving beyond the PD-1/PD-L1 axis
Fabiola ibarra
Clinical and Experimental Immunology, 2021
View PDFchevron_right
Prognostic Impact of PD-L1 Expression in Malignant Salivary Gland Tumors as Assessed by Established Scoring Criteria: Tumor Proportion Score (TPS), Combined Positivity Score (CPS), and Immune Cell (IC) Infiltrate
Armin Riecke
Cancers
View PDFchevron_right
Telltale tumor infiltrating lymphocytes (TIL) in oral, head & neck cancer
Mark Prince
Oral oncology, 2016
View PDFchevron_right
High co-expression of immune checkpoint receptors PD-1, CTLA-4, LAG-3, TIM-3, and TIGIT on tumor-infiltrating lymphocytes in early-stage breast cancer
Mustafa Tükenmez
World Journal of Surgical Oncology
View PDFchevron_right
Expression of Immune Checkpoint Regulators IDO, VISTA, LAG3, and TIM3 in Resected Pancreatic Ductal Adenocarcinoma
Felix Popp
Cancers, 2021
View PDFchevron_right
The Expression of Programmed Death Ligand-1 within Stages of Oral Squamous Cell Carcinoma: Immunohistochemical Analysis
Jabbar Qureshi
Journal of Advances in Medicine and Medical Research
View PDFchevron_right
Prognostic value of arginase-II expression and regulatory T-cell infiltration in head and neck squamous cell carcinoma
Luc Bron
International Journal of Cancer, 2012
View PDFchevron_right
Emerging role of immune checkpoint inhibitors and predictive biomarkers in head and neck cancers
Bene Ekine-Afolabi
Oral Oncology, 2020
View PDFchevron_right
PD-L1 Expression and a High Tumor Infiltrate of CD8+ Lymphocytes Predict Outcome in Patients with Oropharyngeal Squamous Cells Carcinoma
Ernst-jan Speel
International Journal of Molecular Sciences
View PDFchevron_right